Equities

Solution Group Bhd

SOLUTN:KLS

Solution Group Bhd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (MYR)0.135
  • Today's Change0.01 / 8.00%
  • Shares traded175.40k
  • 1 Year change-43.75%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of MYR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments231554
Total Receivables, Net513749
Total Inventory3.483.8731
Prepaid expenses------
Other current assets, total6.34----
Total current assets8455134
Property, plant & equipment, net303333
Goodwill, net----0.01
Intangibles, net0.030.010
Long term investments000
Note receivable - long term00.10--
Other long term assets------
Total assets11488167
LIABILITIES
Accounts payable----26
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.741.060.94
Other current liabilities, total6.083.0513
Total current liabilities238.4840
Total long term debt5.466.126.72
Total debt9.207.187.66
Deferred income tax0.040.030
Minority interest4.682.341.97
Other liabilities, total1.10----
Total liabilities341749
SHAREHOLDERS EQUITY
Common stock898181
Additional paid-in capital------
Retained earnings (accumulated deficit)(9.01)(9.18)38
Treasury stock - common(0.28)(0.28)(0.28)
Unrealized gain (loss)------
Other equity, total----0
Total equity8071118
Total liabilities & shareholders' equity11488167
Total common shares outstanding484440439
Treasury shares - common primary issue1.931.931.93
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.